This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
It is often said during major events in our history that ‘things will never be the same again’. But rather than a single watershed moment, the consequences for industry of COVID-19 - particularly those with global supply chains - are likely to see...
Much has been made of the potential of continuous platforms to supplant traditional pharmaceutical batch manufacturing and drive down API production costs. But how suitable is the technology to the precise requirements of complex pharma processing?
The rush to find effective vaccines against the coronavirus is only one part of the story. How is the pharmaceutical industry addressing the difficult issue of ensuring there will be enough manufacturing capacity to roll them out on a global scale?